{"id":8522,"date":"2024-11-25T10:39:01","date_gmt":"2024-11-25T09:39:01","guid":{"rendered":"https:\/\/www.quinta.cz\/?p=8522"},"modified":"2025-01-21T09:35:18","modified_gmt":"2025-01-21T08:35:18","slug":"biosimilar-development","status":"publish","type":"post","link":"https:\/\/www.quinta.cz\/cs\/2024\/11\/25\/biosimilar-development\/","title":{"rendered":"Expediting Biosimilar development: Streamlining the path from research to market"},"content":{"rendered":"<p>Join Conscio Group upcoming webinar on <strong>December 12 at 2:00 PM CET<\/strong> (<em>expected length up to 2 hours<\/em>), where industry experts will discuss the latest trends in regulation, R&amp;D and clinical testing. In our session we will particularly explore potential regulatory changes regarding the waiver of Phase 3 efficacy studies.<\/p>\n<p><strong>Topics include:<\/strong><\/p>\n<ul>\n<li>Navigating Biosimilar Regulations: Evolution, Challenges, and Future Directions<\/li>\n<li>Common pitfalls on the path from R&amp;D to biotech product commercialization<\/li>\n<li>Strategies for successful bioassay transfer and validation \u2013 the importance of standardization<\/li>\n<\/ul>\n<p><strong>Speakers<\/strong>: Elena Guillen Benitez, MD, PhD from Leiden University Medical Center, Martin Baur from Midas Pharma, and Klemens Weitenthaler from Conscio Group.<\/p>\n<p><strong>Moderator<\/strong>: Stephan Holl, CEO <a href=\"https:\/\/www.consciogroup.com\/\" target=\"_blank\" rel=\"noopener\">Conscio Group<\/a><\/p>\n<h4>Gain insider knowledge on the biosimilar industry \u2013 <a href=\"https:\/\/events.teams.microsoft.com\/event\/ad20d353-d258-4858-b3f0-fbe9089a6762@b6323959-fe7d-41f8-87d1-8d4df7b84eb8\" target=\"_blank\" rel=\"noopener\">register here<\/a>!<\/h4>\n<p><strong><span style=\"color: #007276;\">If you would like to view the recording of the webinar, please contact us today and we will be happy to give you exclusive access to it on our <a href=\"https:\/\/www.youtube.com\/channel\/UCgY_vzhjjQIkYB8ZczXP30g\" target=\"_blank\" rel=\"noopener\">YouTube channel<\/a>.<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On behalf of the Conscio Group, we would like to invite you to a free webinar on the future of the biosimilar pathway to approval, which is now open for registration.<\/p>\n","protected":false},"author":5,"featured_media":8523,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[18],"class_list":["post-8522","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorised","tag-webinar"],"_links":{"self":[{"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/posts\/8522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/comments?post=8522"}],"version-history":[{"count":7,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/posts\/8522\/revisions"}],"predecessor-version":[{"id":8600,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/posts\/8522\/revisions\/8600"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/media\/8523"}],"wp:attachment":[{"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/media?parent=8522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/categories?post=8522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.quinta.cz\/cs\/wp-json\/wp\/v2\/tags?post=8522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}